Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-20-015029)

Filing Details

Accession Number:: 0001213900-20-015029
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-15 17:14:03
Reporting Period:: 2020-06-11

Accepted Time:: 2020-06-15 17:14:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1763950	Lantern Pharma Inc.	LTRN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1393516	Jeffrey D Keyser	C/O Lantern Pharma Inc. 1920 Mckinney Avenue, 7Th Floor Dallas, TX 75201		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-11	10,000	$15.00	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.